March 24 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX
* Receives export and import approvals for clinical studies
* U.S. Drug Enforcement Agency approved export, Australian Office Of Drug Control approved import of synthetic cannabidiol for planned clinical studies Source text for Eikon: ID:nASX4QYDgd Further company coverage: BOT.AX